Diligence memo · auto-generated · as of July 2, 2026
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Thermo Fisher Scientific Inc. operates in Other Health Care, based in WALTHAM.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Thermo Fisher Scientific Inc. has raised $500M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Growth/Late (a round over $400M).
Largest single filing: $500M on 2014-02-03.
Most recent recorded round closed around 2014-02-03.
Valuation (modeled)modeled
Provath models Thermo Fisher Scientific Inc. at approximately $11.8B (range $3.7B–$21.3B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.05× the median modeled value of Growth/Late Other Health Care companies in 2013–2015 (5 peers) — value vs value, same stage and era. Within the normal band (105% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 12.4 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 100% of Other Health Care peers (5377 compared).
Modeled value ranks above 100% of those peers.
Closest niche peers: Hc Group Holdings I, Llc, Inventiv Health Inc, Genesis Healthcare, Inc., CareCore National Group, LLC.
Peoplefiled
18 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.